Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Atg4 in autophagosome biogenesis.

Sánchez-Wandelmer J, Reggiori F.

Oncotarget. 2017 Nov 27;8(65):108290-108291. doi: 10.18632/oncotarget.22714. eCollection 2017 Dec 12. No abstract available.

2.

Atg4 proteolytic activity can be inhibited by Atg1 phosphorylation.

Sánchez-Wandelmer J, Kriegenburg F, Rohringer S, Schuschnig M, Gómez-Sánchez R, Zens B, Abreu S, Hardenberg R, Hollenstein D, Gao J, Ungermann C, Martens S, Kraft C, Reggiori F.

Nat Commun. 2017 Aug 18;8(1):295. doi: 10.1038/s41467-017-00302-3.

3.

Conserved Atg8 recognition sites mediate Atg4 association with autophagosomal membranes and Atg8 deconjugation.

Abreu S, Kriegenburg F, Gómez-Sánchez R, Mari M, Sánchez-Wandelmer J, Skytte Rasmussen M, Soares Guimarães R, Zens B, Schuschnig M, Hardenberg R, Peter M, Johansen T, Kraft C, Martens S, Reggiori F.

EMBO Rep. 2017 May;18(5):765-780. doi: 10.15252/embr.201643146. Epub 2017 Mar 22.

4.

Monitoring the Formation of Autophagosomal Precursor Structures in Yeast Saccharomyces cerevisiae.

Gómez-Sánchez R, Sánchez-Wandelmer J, Reggiori F.

Methods Enzymol. 2017;588:323-365. doi: 10.1016/bs.mie.2016.09.085. Epub 2016 Nov 21.

PMID:
28237109
5.

ERES: sites for autophagosome biogenesis and maturation?

Sanchez-Wandelmer J, Ktistakis NT, Reggiori F.

J Cell Sci. 2015 Jan 15;128(2):185-92. doi: 10.1242/jcs.158758.

6.

Amphisomes: out of the autophagosome shadow?

Sanchez-Wandelmer J, Reggiori F.

EMBO J. 2013 Dec 11;32(24):3116-8. doi: 10.1038/emboj.2013.246. Epub 2013 Nov 12.

7.

Mfn2 modulates the UPR and mitochondrial function via repression of PERK.

Muñoz JP, Ivanova S, Sánchez-Wandelmer J, Martínez-Cristóbal P, Noguera E, Sancho A, Díaz-Ramos A, Hernández-Alvarez MI, Sebastián D, Mauvezin C, Palacín M, Zorzano A.

EMBO J. 2013 Aug 28;32(17):2348-61. doi: 10.1038/emboj.2013.168. Epub 2013 Aug 6. Erratum in: EMBO J. 2014 Jan 13;33(2):171.

8.

Atypical antipsychotics alter cholesterol and fatty acid metabolism in vitro.

Canfrán-Duque A, Casado ME, Pastor O, Sánchez-Wandelmer J, de la Peña G, Lerma M, Mariscal P, Bracher F, Lasunción MA, Busto R.

J Lipid Res. 2013 Feb;54(2):310-24. doi: 10.1194/jlr.M026948. Epub 2012 Nov 21.

9.

Haloperidol disrupts lipid rafts and impairs insulin signaling in SH-SY5Y cells.

Sánchez-Wandelmer J, Dávalos A, de la Peña G, Cano S, Giera M, Canfrán-Duque A, Bracher F, Martín-Hidalgo A, Fernández-Hernando C, Lasunción MA, Busto R.

Neuroscience. 2010 Apr 28;167(1):143-53. doi: 10.1016/j.neuroscience.2010.01.051. Epub 2010 Feb 1.

PMID:
20123000
10.

Effects of the antipsychotic drug haloperidol on the somastostatinergic system in SH-SY5Y neuroblastoma cells.

Sánchez-Wandelmer J, Hernández-Pinto AM, Cano S, Dávalos A, de la Peña G, Puebla-Jiménez L, Arilla-Ferreiro E, Lasunción MA, Busto R.

J Neurochem. 2009 Jul;110(2):631-40. doi: 10.1111/j.1471-4159.2009.06159.x. Epub 2009 May 11.

11.

Inhibition of cholesterol biosynthesis disrupts lipid raft/caveolae and affects insulin receptor activation in 3T3-L1 preadipocytes.

Sánchez-Wandelmer J, Dávalos A, Herrera E, Giera M, Cano S, de la Peña G, Lasunción MA, Busto R.

Biochim Biophys Acta. 2009 Sep;1788(9):1731-9. doi: 10.1016/j.bbamem.2009.05.002. Epub 2009 May 9.

Supplemental Content

Loading ...
Support Center